Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT01262560
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Patients being treated with combination chemotherapy (definitive or adjuvant) and radiation therapy once daily for small cell or non-small cell lung cancer (primary population for the trial)
* Patients can receive chemoradiotherapy while on a Radiation Therapy Oncology Group (RTOG) lung trial or while not being on a clinical trial
* No patients receiving chemoradiotherapy while enrolled on a single institution trial or trials coordinated by other cooperative groups
* No patients with metastatic disease
* At least 5 cm of the esophagus must be in the 60 Gy isodose volume in 1.6 to 2.0 Gy fractions
PATIENT CHARACTERISTICS:
* Age 18 and up
* Able to swallow thick liquids prior to treatment
* Able to speak English or Spanish in order to complete required forms (verbal completion is adequate)
* No patients with poorly controlled diabetes
* No known hypersensitivity to honey
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No patients who have received prior chemotherapy or radiation therapy
* No patients receiving more than once daily treatments
* Therapeutic use of honey other than the Manuka honey provided for this trial is not allowed while patients are on study
* Patients must also avoid honey-flavored medical products and/or sugary, viscous substances
* Amifostine is not permitted
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01262560
Study Brief:
Protocol Section:
NCT01262560